documents: FDA-2015-P-2820-0064

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2015-P-2820-0064 FDA FDA-2015-P-2820 Exhibit 11 The Pharmaletter, ANSM continues investigations into Bial clinical trial death, March 10, 2016 re: Amendment from Center for Responsible Science Supporting & Related Material Background Material 2016-03-21T04:00:00Z 2016 3     2016-03-21T14:51:57Z   0 0 0900006481ecf19d

Links from other tables